Page last updated: 2024-09-02

perindopril and Benign Neoplasms

perindopril has been researched along with Benign Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chee, A; Lynch, GS; Murphy, KT; Naim, T; Trieu, J	1
Chalmers, J; Cooper, ME; Mancia, G; Marre, M; Morton, J; Ng, MK; Poulter, NR; Woodward, M; Zoungas, S	1
Fukui, H; Ikenaka, Y; Kawata, M; Kuriyama, S; Nakatani, T; Noguchi, R; Tsujinoue, H; Yoshii, J; Yoshiji, H	1
Fukui, H; Kuriyama, S; Yoshiji, H	1

Reviews

1 review(s) available for perindopril and Benign Neoplasms

Article	Year
Perindopril: possible use in cancer therapy. Anti-cancer drugs, 2002, Volume: 13, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelial Growth Factors; Gene Expression; Humans; Neoplasms; Neovascularization, Pathologic; Perindopril	2002

Trials

1 trial(s) available for perindopril and Benign Neoplasms

Article	Year
The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality? Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013, Volume: 22, Issue:9 Topics: Australia; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Humans; Incidence; Indapamide; Male; Middle Aged; Neoplasms; Perindopril; Proportional Hazards Models; Risk Factors; Treatment Outcome	2013

Article

Year

The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality?

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013, Volume: 22, Issue:9

Topics: Australia; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Humans; Incidence; Indapamide; Male; Middle Aged; Neoplasms; Perindopril; Proportional Hazards Models; Risk Factors; Treatment Outcome

2013

Other Studies

2 other study(ies) available for perindopril and Benign Neoplasms

Article	Year
Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia. International journal of cancer, 2013, Sep-01, Volume: 133, Issue:5 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cachexia; Cell Line, Tumor; Interleukin-6; Male; Mice; Motor Activity; Muscle Fatigue; Muscle Proteins; Muscle, Skeletal; Neoplasms; Perindopril; Tripartite Motif Proteins; Ubiquitin-Protein Ligases	2013
The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:4 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cell Line, Transformed; Disease Models, Animal; Endothelial Growth Factors; Gene Expression; Lymphokines; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Perindopril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Transplantation, Homologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2001

Article

Year

Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia.

International journal of cancer, 2013, Sep-01, Volume: 133, Issue:5

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cachexia; Cell Line, Tumor; Interleukin-6; Male; Mice; Motor Activity; Muscle Fatigue; Muscle Proteins; Muscle, Skeletal; Neoplasms; Perindopril; Tripartite Motif Proteins; Ubiquitin-Protein Ligases

2013

The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:4

Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cell Line, Transformed; Disease Models, Animal; Endothelial Growth Factors; Gene Expression; Lymphokines; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Perindopril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Transplantation, Homologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2001